HIV news from aidsmap.com

CD8 cell fitness predicts who benefits most from antibody-based cure strategies
Over the last few years a number of studies aiming to cure HIV or at least achieve long-term viral suppression off antiretroviral therapy (ART) have produced tantalising results. These studies have given participants one or both of the long-acting versions of two broadly neutralising antibodies (bnAbs), 3BNC117 (teropavimab) and 10-1074 (zinlirvimab), sometimes in conjunction with immune boosting oral drugs.
>> Read more

News from CROI 2026 coming soon
The 33rd Conference on Retroviruses and Opportunistic Infections (CROI 2026) is taking place in Denver, US, from 22 to 25 February. CROI is an annual scientific conference and was established to “provide a forum for basic scientists and clinical investigators to present, discuss, and critique their investigations into the epidemiology and biology of human retroviruses and associated diseases”. CROI 2026 will feature research and discussions on:
>> Read more

Immigration and poverty tied to heightened HIV risk in the Netherlands
There is a strong social gradient associated with HIV diagnoses in the Netherlands, Dr Vita Jongen from Stichting HIV Monitoring and colleagues report in The Lancet Regional Health – Europe. People who are poorer or are first-generation immigrants are much more likely to be diagnosed with HIV, while intersections between poverty and migration further increase their vulnerability.
>> Read more